Armata Pharmaceuticals (ARMP) News
NYSE: ARMPHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.03+0.05 (+1.68%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ARMP news summary
We found 2 recent headlines mentioning Armata Pharmaceuticals (ARMP): 0 in the past week and 2 in the past 30 days, most often from PR Newswire, Nasdaq. For price context, ARMP is up 1.68% at $3.03. The most recent story, "Armata Pharmaceuticals Announces Financial Results for the Third Quarter 2026 and Provides Corporate Update", was published by PR Newswire on Nov 12, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Armata Pharmaceuticals headlines
- Armata Pharmaceuticals Announces Financial Results for the Third Quarter 2026 and Provides Corporate UpdateLOS ANGELES, Nov. 12, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of…PR Newswire
- Krystal Biotech, Inc. (KRYS) Surpasses Q3 Earnings and Revenue EstimatesKrystal Biotech (KRYS) delivered earnings and revenue surprises of +11.41% and +2.16%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?NasdaqKRYS, ARMP